These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

356 related items for PubMed ID: 33222700

  • 1. Regional binding of tau and amyloid PET tracers in Down syndrome autopsy brain tissue.
    Lemoine L, Ledreux A, Mufson EJ, Perez SE, Simic G, Doran E, Lott I, Carroll S, Bharani K, Thomas S, Gilmore A, Hamlett ED, Nordberg A, Granholm AC.
    Mol Neurodegener; 2020 Nov 23; 15(1):68. PubMed ID: 33222700
    [Abstract] [Full Text] [Related]

  • 2. Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases.
    Malarte ML, Nordberg A, Lemoine L.
    Eur J Nucl Med Mol Imaging; 2021 Apr 23; 48(4):1093-1102. PubMed ID: 32970217
    [Abstract] [Full Text] [Related]

  • 3. Discriminative binding of tau PET tracers PI2620, MK6240 and RO948 in Alzheimer's disease, corticobasal degeneration and progressive supranuclear palsy brains.
    Malarte ML, Gillberg PG, Kumar A, Bogdanovic N, Lemoine L, Nordberg A.
    Mol Psychiatry; 2023 Mar 23; 28(3):1272-1283. PubMed ID: 36447011
    [Abstract] [Full Text] [Related]

  • 4. Cortical laminar tau deposits and activated astrocytes in Alzheimer's disease visualised by 3H-THK5117 and 3H-deprenyl autoradiography.
    Lemoine L, Saint-Aubert L, Nennesmo I, Gillberg PG, Nordberg A.
    Sci Rep; 2017 Apr 04; 7():45496. PubMed ID: 28374768
    [Abstract] [Full Text] [Related]

  • 5. Visualization of regional tau deposits using (3)H-THK5117 in Alzheimer brain tissue.
    Lemoine L, Saint-Aubert L, Marutle A, Antoni G, Eriksson JP, Ghetti B, Okamura N, Nennesmo I, Gillberg PG, Nordberg A.
    Acta Neuropathol Commun; 2015 Jul 02; 3():40. PubMed ID: 26134112
    [Abstract] [Full Text] [Related]

  • 6. Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.
    Lemoine L, Gillberg PG, Svedberg M, Stepanov V, Jia Z, Huang J, Nag S, Tian H, Ghetti B, Okamura N, Higuchi M, Halldin C, Nordberg A.
    Alzheimers Res Ther; 2017 Dec 11; 9(1):96. PubMed ID: 29229003
    [Abstract] [Full Text] [Related]

  • 7. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants: AβPParc and PSEN1DE9.
    Lemoine L, Gillberg PG, Bogdanovic N, Nennesmo I, Saint-Aubert L, Viitanen M, Graff C, Ingelsson M, Nordberg A.
    Mol Psychiatry; 2021 Oct 11; 26(10):5609-5619. PubMed ID: 32581318
    [Abstract] [Full Text] [Related]

  • 8. The relationships between neuroinflammation, beta-amyloid and tau deposition in Alzheimer's disease: a longitudinal PET study.
    Ismail R, Parbo P, Madsen LS, Hansen AK, Hansen KV, Schaldemose JL, Kjeldsen PL, Stokholm MG, Gottrup H, Eskildsen SF, Brooks DJ.
    J Neuroinflammation; 2020 May 06; 17(1):151. PubMed ID: 32375809
    [Abstract] [Full Text] [Related]

  • 9. Imaging in-vivo tau pathology in Alzheimer's disease with THK5317 PET in a multimodal paradigm.
    Chiotis K, Saint-Aubert L, Savitcheva I, Jelic V, Andersen P, Jonasson M, Eriksson J, Lubberink M, Almkvist O, Wall A, Antoni G, Nordberg A.
    Eur J Nucl Med Mol Imaging; 2016 Aug 06; 43(9):1686-99. PubMed ID: 26996778
    [Abstract] [Full Text] [Related]

  • 10. S-[18F]THK-5117-PET and [11C]PIB-PET Imaging in Idiopathic Normal Pressure Hydrocephalus in Relation to Confirmed Amyloid-β Plaques and Tau in Brain Biopsies.
    Leinonen V, Rauramaa T, Johansson J, Bottelbergs A, Tesseur I, van der Ark P, Pemberton D, Koivisto AM, Jääskeläinen JE, Hiltunen M, Herukka SK, Blennow K, Zetterberg H, Jokinen P, Rokka J, Helin S, Haaparanta-Solin M, Solin O, Okamura N, Kolb HC, Rinne JO.
    J Alzheimers Dis; 2018 Aug 06; 64(1):171-179. PubMed ID: 29865068
    [Abstract] [Full Text] [Related]

  • 11. PET imaging of tau protein targets: a methodology perspective.
    Lois C, Gonzalez I, Johnson KA, Price JC.
    Brain Imaging Behav; 2019 Apr 06; 13(2):333-344. PubMed ID: 29497982
    [Abstract] [Full Text] [Related]

  • 12. In vitro Characterization of the Regional Binding Distribution of Amyloid PET Tracer Florbetaben and the Glia Tracers Deprenyl and PK11195 in Autopsy Alzheimer's Brain Tissue.
    Ni R, Röjdner J, Voytenko L, Dyrks T, Thiele A, Marutle A, Nordberg A.
    J Alzheimers Dis; 2021 Apr 06; 80(4):1723-1737. PubMed ID: 33749648
    [Abstract] [Full Text] [Related]

  • 13. Prodromal neuroinflammatory, cholinergic and metabolite dysfunction detected by PET and MRS in the TgF344-AD transgenic rat model of AD: a collaborative multi-modal study.
    Chaney AM, Lopez-Picon FR, Serrière S, Wang R, Bochicchio D, Webb SD, Vandesquille M, Harte MK, Georgiadou C, Lawrence C, Busson J, Vercouillie J, Tauber C, Buron F, Routier S, Reekie T, Snellman A, Kassiou M, Rokka J, Davies KE, Rinne JO, Salih DA, Edwards FA, Orton LD, Williams SR, Chalon S, Boutin H.
    Theranostics; 2021 Apr 06; 11(14):6644-6667. PubMed ID: 34093845
    [Abstract] [Full Text] [Related]

  • 14. PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).
    Rafii MS, Lukic AS, Andrews RD, Brewer J, Rissman RA, Strother SC, Wernick MN, Pennington C, Mobley WC, Ness S, Matthews DC, Down Syndrome Biomarker Initiative and the Alzheimer’s Disease Neuroimaging Initiative.
    J Alzheimers Dis; 2017 Apr 06; 60(2):439-450. PubMed ID: 28946567
    [Abstract] [Full Text] [Related]

  • 15. Novel 18F-labeled arylquinoline derivatives for noninvasive imaging of tau pathology in Alzheimer disease.
    Okamura N, Furumoto S, Harada R, Tago T, Yoshikawa T, Fodero-Tavoletti M, Mulligan RS, Villemagne VL, Akatsu H, Yamamoto T, Arai H, Iwata R, Yanai K, Kudo Y.
    J Nucl Med; 2013 Aug 06; 54(8):1420-7. PubMed ID: 23857514
    [Abstract] [Full Text] [Related]

  • 16. Unique Pathology in the Locus Coeruleus of Individuals with Down Syndrome.
    Saternos H, Hamlett ED, Guzman S, Head E, Granholm AC, Ledreux A.
    J Alzheimers Dis; 2024 Aug 06; 101(2):541-561. PubMed ID: 39213062
    [Abstract] [Full Text] [Related]

  • 17. Brain Amyloid-β Deposition and Blood Biomarkers in Patients with Clinically Diagnosed Alzheimer's Disease.
    Li WW, Shen YY, Tian DY, Bu XL, Zeng F, Liu YH, Chen Y, Yao XQ, Li HY, Chen DW, Zhou FY, Yang H, Li QM, Bao WQ, Guan YH, Zhou HD, Jin RB, Wang YJ.
    J Alzheimers Dis; 2019 Aug 06; 69(1):169-178. PubMed ID: 30958377
    [Abstract] [Full Text] [Related]

  • 18. Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome.
    Rafii MS.
    Dev Neurobiol; 2019 Jul 06; 79(7):711-715. PubMed ID: 30536948
    [Abstract] [Full Text] [Related]

  • 19. The Sensitivity of Tau Tracers for the Discrimination of Alzheimer's Disease Patients and Healthy Controls by PET.
    Mohammadi Z, Alizadeh H, Marton J, Cumming P.
    Biomolecules; 2023 Feb 03; 13(2):. PubMed ID: 36830659
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.